NK Cell-Fc Receptors Advance Tumor Immunotherapy

Immunotherapy has revolutionized the treatment of cancer patients. Among immunotherapeutic approaches, antibodies targeting immune checkpoint inhibitors Programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are approved for treatment of metastatic melanoma a...

Descripción completa

Detalles Bibliográficos
Autor principal: Sanseviero, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832859/
https://www.ncbi.nlm.nih.gov/pubmed/31614774
http://dx.doi.org/10.3390/jcm8101667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832859/
https://www.ncbi.nlm.nih.gov/pubmed/31614774
http://dx.doi.org/10.3390/jcm8101667

Ejemplares similares